Identification of Drivers from Cancer Genome Diversity in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers with a dismal outcome. The complicated molecular pathogenesis of HCC caused by tumor heterogeneity makes it difficult to identify druggable targets useful for treating HCC patients. One approach that has a potential for the improvemen...
Main Authors: | Atsushi Takai, Hien T. Dang, Xin W. Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/15/6/11142 |
Similar Items
-
Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes
by: Ziyu Liu, et al.
Published: (2020-06-01) -
Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma
by: Gao Li, et al.
Published: (2021-07-01) -
Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
by: Loraine Kay D. Cabral, et al.
Published: (2020-06-01) -
Comprehensive Characterization of Immunological Profiles and Clinical Significance in Hepatocellular Carcinoma
by: Ping Tao, et al.
Published: (2021-01-01) -
Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes
by: Keyan Wang, et al.
Published: (2020-05-01)